BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34217060)

  • 1. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.
    Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y
    Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
    Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
    J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
    Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives.
    Guillon J; Reynolds RC; Leger JM; Guie MA; Massip S; Dallemagne P; Jarry C
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):489-95. PubMed ID: 15662953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
    Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
    Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
    Santivañez-Veliz M; Pérez-Silanes S; Torres E; Moreno-Viguri E
    Bioorg Med Chem Lett; 2016 May; 26(9):2188-93. PubMed ID: 27025343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents.
    Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
    Vicente E; Villar R; Burguete A; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3321-6. PubMed ID: 18625764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of antimycobacterials.
    Keri RS; Pandule SS; Budagumpi S; Nagaraja BM
    Arch Pharm (Weinheim); 2018 May; 351(5):e1700325. PubMed ID: 29611626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
    Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
    J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
    Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
    Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
    Ancizu S; Moreno E; Torres E; Burguete A; Pérez-Silanes S; Benítez D; Villar R; Solano B; Marín A; Aldana I; Cerecetto H; González M; Monge A
    Molecules; 2009 Jun; 14(6):2256-72. PubMed ID: 19553897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.